210
Views
42
CrossRef citations to date
0
Altmetric
Original Articles

Optimal Development of a New Stable Nutraceutical Nanoemulsion Based on the Inclusion Complex of 2-Hydroxypropyl-β-cyclodextrin with Canthaxanthin Accumulated by Dietzia natronolimnaea HS-1 Using Ultrasound-Assisted Emulsification

, &
Pages 614-625 | Received 16 Apr 2014, Accepted 01 May 2014, Published online: 20 Dec 2014
 

Abstract

Solubilizing the potent anticancer pigments in nanoemulsion (NE) systems containing 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) is a novel and promising strategy to incorporate them into water-based drug formulations. The concentration effects of sunflower oil (SO, 5.61–17.39% w/w), surfactant mixture of Tween 80 (T80) and Span 20 (S20) (1:1 weight ratio, 3.95–14.05% w/w), and the inclusion complex of HP-β-CD with canthaxanthin (CTX) synthesized by Dietzia natronolimnaea HS-1 (2.61–14.39% w/w) were evaluated to formulate a stable NE using ultrasound-assisted emulsification. The NEs were evaluated regarding droplet size and polydispersity index (span), physical stability, turbidity, and loss of antioxidant activity (LAA). Response surface modeling showed that the NEs containing 12% T80/S20, 8.30% SO, and 12% CTX/HP-β-CD had the lowest droplet size (105.5 nm), span (0.394), droplet growth ratio (0.112), turbidity (0.139), and LAA (9.36%). The predicted values obtained were close to the experimental values, indicating the suitability of the constructed models. Transmission electron microscopy and confocal laser-scanning microscopy also demonstrated that the formed droplets of the NEs produced at optimal formulation were spherical in the range of 20–100 nm. A significant correlation was found between droplet size with stability (r = −0.960, p < 0.01) and turbidity (r 2 = 0.876, p < 0.01) values.

GRAPHICAL ABSTRACT

Notes

Color versions of one or more of the figures in the article can be found online at www.tandfonline.com/ldis.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.